Emergency Department–Initiated Buprenorphine for Opioid Use Disorder

JAMA 2026

View at publisher
DOI: 10.1001/jama.2025.27064
Cited by: 0

Abstract

This trial examined whether 7-day extended-release injectable buprenorphine given in the emergency department (ED) improved treatment engagement at 7 days vs sublingual buprenorphine among adults with untreated opioid use disorder.

Fields of Study & Subjects

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Pain Management and Opioid Use

Publication details

Journal / source
JAMA
Volume
335
Issue
11
Pages
e2527064–e2527064
Publication date
11 February 2026
Language
EN